InvestorsObserver
×
News Home

Is Werewolf Therapeutics Inc (HOWL) a Leader in the Biotechnology Industry?

Tuesday, October 31, 2023 12:07 PM | InvestorsObserver Analysts

Mentioned in this article

Is Werewolf Therapeutics Inc (HOWL) a Leader in the Biotechnology Industry?

The 68 rating InvestorsObserver gives to Werewolf Therapeutics Inc (HOWL) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 87 percent of stocks in the Biotechnology industry, HOWL’s 68 overall rating means the stock scores better than 68 percent of all stocks.

Overall Score - 68
HOWL has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on HOWL!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 68 would rank higher than 68 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Werewolf Therapeutics Inc Stock Today?

Werewolf Therapeutics Inc (HOWL) stock has fallen -0.98% while the S&P 500 has risen 0.13% as of 12:06 PM on Tuesday, Oct 31. HOWL has fallen -$0.02 from the previous closing price of $2.52 on volume of 489,999 shares. Over the past year the S&P 500 has risen 7.75% while HOWL has fallen -15.54%. HOWL lost -$1.28 per share the over the last 12 months. Click Here to get the full Stock Report for Werewolf Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App